NEW YORK (GenomeWeb) — Thermo Fisher Scientific and NX Prenatal said today that they have partnered on the development of mass spectrometry-based proteomics assays for adverse pregnancy outcomes.
NEW YORK (GenomeWeb) — Thermo Fisher Scientific and NX Prenatal said today that they have partnered on the development of mass spectrometry-based proteomics assays for adverse pregnancy outcomes.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.